Labshake search

Citations for Selleck Chemicals :

1 - 4 of 4 citations for "S1001" since 2019

Citations are collected from bioRxiv only, the total number of publications could be much larger.

Cell line-specific network models of ER+ breast cancer identify PI3Kα inhibitor sensitivity factors and drug combinations

Jorge Gómez Tejeda Zañudo, et al., bioRxiv - Cancer Biology 2020

Quote: ... navitoclax (Selleck Chemicals # S1001), fulvestrant (Sigma Aldrich # I4409) ...

Product cited:

Navitoclax (ABT-263)

Navitoclax (ABT-263) is a potent inhibitor of Bcl-xL, Bcl-2 and Bcl-w with Ki of ≤ 0.5 nM, ≤1 nM...

Cat# S1001, SKU# S1001-25mg, 25mg, $237.00 Ask
A Fully-Automated Senescence Test (FAST) for the high-throughput quantification of senescence-associated markers

Francesco Neri, et al., bioRxiv - Cell Biology 2024

Quote: ... cells were treated with the senolytic ABT263/Navitoclax (Selleck Chemicals, S1001) at different concentrations for 24 h ...

Product cited:

Navitoclax (ABT-263)

Navitoclax (ABT-263) is a potent inhibitor of Bcl-xL, Bcl-2 and Bcl-w with Ki of ≤ 0.5 nM, ≤1 nM...

Cat# S1001, SKU# S1001-25mg, 25mg, $237.00 Ask
Senescent cell heterogeneity and responses to senolytic treatment are related to cell cycle status during cell growth arrest

Francesco Neri, et al., bioRxiv - Cell Biology 2024

Quote: ... cells were treated with the senolytic ABT263/Navitoclax (Selleck Chemicals, S1001) at different concentrations for 24 h ...
Senescent cells and macrophages cooperate through a multi-kinase signaling network to promote intestinal transformation in Drosophila

Ishwaree Datta, Erdem Bangi, bioRxiv - Cancer Biology 2023

Quote: Drug concentrations used in this study are as follows: navitoclax (10uM Selleck Chemicals #S1001), fisetin (10uM ...

Product cited:

Navitoclax (ABT-263)

Navitoclax (ABT-263) is a potent inhibitor of Bcl-xL, Bcl-2 and Bcl-w with Ki of ≤ 0.5 nM, ≤1 nM...

Cat# S1001, SKU# S1001-25mg, 25mg, $237.00 Ask

Feedback